Amgen’s proposed acquisition of Horizon Therapeutics for $28.7 billion, including debt, would be the largest healthcare deal since AstraZeneca’s $39 billion purchase of...
30.11.2017
- In a provisional ruling announced on Nov. 21, the UK’s Competition and Markets Authority (CMA) has found that Canadian pharma Concordia abused its dominant position to overcharge...
29.07.2015
- French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...
